Global estimates of prevalent and incident herpes simplex virus type 2 infections in 2012, PLoS One, vol.10, p.114989, 2015. ,
Association between cervical shedding of herpes simplex virus and HIV-1, AIDS, vol.16, pp.2425-2455, 2002. ,
Correlates of HIV-1 genital shedding in Tanzanian women, PLoS One, vol.6, p.17480, 2011. ,
Proinflammatory cytokines and chemokines -but not interferon-beta -produced in response to HSV-2 in primary human genital epithelial cells are associated with viral replication and the presence of the virion host shutoff protein, Am J Reprod Immunol, vol.70, pp.199-212, 2013. ,
Virologic and immunologic evidence of multifocal genital herpes simplex virus 2 infection, J Virol, vol.88, pp.4921-4952, 2014. ,
Severe genital herpes infections in HIV-infected individuals with impaired herpes simplex virus-specific CD8+ cytotoxic T lymphocyte responses, Proc Natl Acad Sci U S A, vol.94, pp.10289-94, 1997. ,
Roles of clinical and subclinical reactivated herpes simplex virus type 2 infection and human immunodeficiency virus type 1 (HIV-1)-induced immunosuppression on genital and plasma HIV-1 levels, J Infect Dis, vol.198, pp.241-250, 2008. ,
Increased genital shedding of herpes simplex virus type 2 in HIV-seropositive women, Ann Intern Med, vol.123, pp.845-852, 1995. ,
Genital shedding of herpes simplex virus among symptomatic and asymptomatic persons with HSV-2 infection, JAMA, vol.305, pp.1441-1450, 2011. ,
Virologic characteristics of subclinical and symptomatic genital herpes infections, N Engl J Med, vol.333, pp.770-775, 1995. ,
Rapidly cleared episodes of herpes simplex virus reactivation in immunocompetent adults, J Infect Dis, vol.198, pp.1141-1150, 2008. ,
Increased risk of genital ulcer disease in women during the first month after initiating antiretroviral therapy, J Acquir Immune Defic Syndr, vol.52, pp.600-603, 2009. ,
Reactivation of herpes simplex virus type 2 after initiation of antiretroviral therapy, J Infect Dis, vol.208, pp.839-885, 2013. ,
Spectrum of commercial sex activity in Burkina Faso: classification model and risk of exposure to HIV, J Acquir Immune Defic Syndr, vol.29, pp.517-538, 2002. ,
Genital warts and infection with human immunodeficiency virus in high-risk women in Burkina Faso: a longitudinal study, BMC Infect Dis, vol.11, p.20, 2011. ,
Long term virological, immunological and mortality outcomes in a cohort of HIV-infected female sex workers treated with highly active antiretroviral therapy in Africa, BMC Public Health, vol.11, p.700, 2011. ,
URL : https://hal.archives-ouvertes.fr/inserm-00631427
, Scaling up antiretroviral therapy in resource-limited settings guidelines for a public health approach. Geneva: World Health Organization, 2002.
Reduction of HIV-1 RNA levels with therapy to suppress herpes simplex virus, N Engl J Med, vol.356, pp.790-799, 2007. ,
Impact of suppressive herpes therapy on genital HIV-1 RNA among women taking antiretroviral therapy: a randomized controlled trial, AIDS, vol.20, pp.2305-2318, 2006. ,
Longitudinal assessment of HIV-1 and HSV-2 shedding in the genital tract of West African women, J Acquir Immune Defic Syndr, vol.39, pp.632-636, 2005. ,
Comparison of the Generic HIV Viral Load assay with the Amplicor HIV-1 monitor v1.5 and Nuclisens HIV-1 EasyQ v1.2 techniques for plasma HIV-1 RNA quantitation of non-B subtypes: the Kesho Bora preparatory study, J Virol Methods, vol.163, pp.253-260, 2010. ,
Detection and subtyping of Herpes simplex virus in clinical samples by LightCycler PCR, enzyme immunoassay and cell culture, BMC Microbiol, vol.2, p.12, 2002. ,
Neisseria gonorrhoeae and Chlamydia trachomatis infection in HIV-1-infected women taking antiretroviral therapy: a prospective cohort study from Burkina Faso, Sex Transm Infect, vol.90, pp.100-103, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-02095253
Detection of Y chromosome DNA as evidence of semen in cervicovaginal secretions of sexually active women, Clin Diagn Lab Immunol, vol.8, pp.955-963, 2001. ,
, Panel on Antiretroviral Guidelines for Adults and Adolescents, Department of Health and Human Services. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents, 2015.
Quantitative and qualitative correlates of cervicovaginal herpes simplex virus type 2 shedding among HIV-infected women in the Women's Interagency HIV Study, Int J STD AIDS, vol.22, pp.273-280, 2011. ,
Reconstitution of herpes simplex virusspecific T cell immunity in HIV-infected patients receiving highly active antiretroviral therapy, J Infect Dis, vol.195, pp.410-415, 2007. ,
Relationship between herpes simplex virus ulceration and CD4+ cell counts in patients with HIV infection, AIDS, vol.6, pp.1317-1337, 1992. ,
Herpes simplex virus and HIV-1: deciphering viral synergy, Lancet Infect Dis, vol.8, pp.490-497, 2008. ,
Negative mucosal synergy between Herpes simplex type 2 and HIV in the female genital tract, AIDS, vol.21, pp.589-98, 2007. ,
Coinfection with herpes simplex virus type 2 is associated with reduced HIV-specific T cell responses and systemic immune activation, J Infect Dis, vol.197, pp.1394-401, 2008. ,
Cervicovaginal HIV-1 shedding in women taking antiretroviral therapy in Burkina Faso: a longitudinal study, J Acquir Immune Defic Syndr, vol.65, pp.237-282, 2014. ,
Frequent reactivation of herpes simplex virus among HIV-1-infected patients treated with highly active antiretroviral therapy, J Infect Dis, vol.190, pp.693-699, 2004. ,
Antiretroviral therapy is not associated with reduced herpes simplex virus shedding in HIV coinfected adults: an observational cohort study, BMJ Open, vol.4, p.4210, 2014. ,
Impact of acyclovir on genital and plasma HIV-1 RNA, genital herpes simplex virus type 2 DNA, and ulcer healing among HIV-1-infected African women with herpes ulcers: a randomized placebo-controlled trial, J Infect Dis, vol.200, pp.216-242, 2009. ,
Cervicovaginal HIV-1 and herpes simplex virus type 2 shedding during genital ulcer disease episodes, AIDS, vol.21, pp.1569-78, 2007. ,
Genital herpes evaluation by quantitative TaqMan PCR: correlating single detection and quantity of HSV-2 DNA in cervicovaginal lavage fluids with cross-sectional and longitudinal clinical data, Virol J, vol.7, p.328, 2010. ,